Actively Recruiting
Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease
Led by Centre for Addiction and Mental Health · Updated on 2024-12-13
50
Participants Needed
1
Research Sites
44 weeks
Total Duration
On this page
Sponsors
C
Centre for Addiction and Mental Health
Lead Sponsor
S
St. Mary's Research Center, Canada
Collaborating Sponsor
AI-Summary
What this Trial Is About
Behavioural and psychological symptoms of dementia (BPSD), such as depression affect up to 90% patients with dementia. Non-pharmacological treatment of BPSD, can be difficult to access, require caregiver support, travel, and often have long waiting lists. Virtual reality (VR) is an innovative, portable, immersive, and accessible technology which can be used in-home. More information is required on the feasibility of using VR in-home with older adults with dementia. Our study will offer a 4-week program of 15-minutes sessions, twice per week nature-based VR program for BPSD delivered in-home by virtual reality (VR). Additionally, caregivers will have the option of taking part in the study and provide feedback regarding the VR intervention. If successful, this project has the potential to prolong aging in place for individuals with BPSD, as BPSD is a significant factor in institutionalization.
CONDITIONS
Official Title
Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of mild to early-moderate Alzheimer's disease or mixed dementia with Alzheimer's using DSM-5 criteria
- Age 50 years or older
- Medically stable to participate in the trial
- Patient Health Questionnaire score between 5 and 14
- Comfortable with technology as judged by investigator
- Access to WiFi and a smart device for WebEx and app downloads
- Have someone available to be present during all sessions
You will not qualify if you...
- Unstable medical or psychiatric condition, including substance use, as judged by investigator
- Visual or hearing impairments that would interfere with participation
- Patient Health Questionnaire score 15 to 27 and/or score of 1 or 2 in section E question 1 of the Cornell Scale for Depression in Dementia
- Any condition making study participation intolerable in the opinion of the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre for Addictions and Mental Health (CAMH)
Toronto, Ontario, Canada, L5V 2X3
Actively Recruiting
Research Team
A
Ashnie Sukhu, BSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here